Common questions about Hialuronidasa (FAQ)
Q: Is Hialuronidasa the same as Hyaluronic Acid?
No, they are different substances. Hialuronidasa is classified in official documents as an enzyme (Hyaluronate Glycanohydrolase). Its fundamental purpose is to act upon and temporarily break down Hyaluronic Acid (HA), which is the large, natural molecule that gives connective tissue its viscosity.
Q: Can Hialuronidasa cause a rash or redness?
Yes, official documentation reports that localized erythema (redness) and pain at the injection site are among the most frequently reported temporary reactions. Systemic allergic reactions, which may involve a generalized rash (urticaria) or hives, have also been reported, while these systemic allergic responses have been documented as rare.
Q: Is it possible to be allergic to Hialuronidasa?
Yes, there is a possibility of an allergic response. The product information states that the drug is formally contraindicated (should not be used) in people with a known hypersensitivity or allergy to the drug or any of its ingredients. Rare but serious allergic responses, such as anaphylactic-like reactions, have been documented.
Q: What happens if I receive Hialuronidasa while taking blood thinners?
Official regulatory documents specifically note that co-administration with systemic doses of Salicylates (a class of drugs that includes some blood thinners) may interfere with the enzyme. This can make the tissue partially resistant to the enzyme’s action, potentially requiring a larger quantity of Hialuronidasa to achieve the necessary dispersal effect.
Q: Can pregnant women be given Hialuronidasa?
Regulatory information advises that use during pregnancy should be avoided unless clearly needed, as the safety of the product for human pregnancy has not been established in controlled clinical studies. Official guidance indicates that the potential benefit versus unknown risks should be considered.
Q: Can elderly patients use Hialuronidasa without special precautions?
Use in the elderly is established. However, official documents emphasize the need for special care when the enzyme is used to facilitate the administration of subcutaneous fluids. This special care is related to avoiding over-hydration, especially if a patient has or is suspected to have underlying renal impairment (kidney problems).
Q: What information is available regarding Hialuronidasa use during breastfeeding?
Official regulatory information states that caution is advised for nursing mothers. This is because it is currently unknown if the medicine passes into human milk, and therefore, the potential risks to the infant compared to the maternal benefit should be considered.
Q: What are the known severe adverse reactions to Hialuronidasa?
The most serious reactions reported, though classified as rare (less than 0.1%), involve systemic allergic responses. These reactions include severe Anaphylactic-like reactions and generalized Hypersensitivity reactions, which are recognized in the official adverse reactions summaries.
Q: How quickly does Hialuronidasa start to work?
The action of the enzyme is local. When Hialuronidasa is used as an adjunct to a local anesthetic, regulatory documents state that this co-administration may hasten the onset (speed up the start) of the anesthetic effect, as its local action initiates the temporary breakdown of tissue viscosity.
Q: How long do the effects of Hialuronidasa last?
The effect on tissue permeability is temporary, as the enzyme is rapidly broken down in the body. For instance, when it is co-administered with a local anesthetic, regulatory documents note that the enzyme's action shortens the duration of the anesthetic effect compared to when the anesthetic is used alone.
Q: Does Hialuronidasa interact with common pain relievers like ibuprofen?
Official regulatory documents do not specifically list common non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen as a direct incompatibility. However, the label does note that other anti-inflammatory drugs, specifically Salicylates, may act as antagonists and reduce the enzyme's dispersal effect.
Q: What is the difference between hyaluronidase and Hialuronidasa?
The terms refer to the same active ingredient. Hyaluronidase is the recognized international non-proprietary name (INN) and chemical name for the enzyme. Hialuronidasa is simply an alternate common spelling or nomenclature used in certain regions or documents.
Q: Can people with kidney problems use Hialuronidasa?
Specific guidelines for the general population with kidney problems are not detailed in the product information. However, regulatory text does advise special care in older adults with suspected renal impairment to ensure the controlled rate and volume of fluids delivered when the drug is used as a facilitating agent.
Q: What kind of research has been done on Hialuronidasa?
Studies cited in official medical literature focus on its use for facilitating fluid administration under the skin (hypodermoclysis), as an adjunct to local anesthesia, and in specific interventions to address complications related to hyaluronic acid dermal fillers.
Q: Are there any long-term effects of using Hialuronidasa that studies have shown?
Regulatory summaries explicitly state that the long-term effects of the enzyme's use have not been fully established. Nonclinical toxicology and long-term studies to assess effects like carcinogenicity have not been performed in animals, according to available data.
Q: Does the medicine Hialuronidasa contain any animal products?
Hialuronidasa can be sourced in different ways. Modern products are commonly Recombinant human hyaluronidase (rHuPH20), which is synthetically produced. Historically, some preparations were of biological origin derived from animal sources, such as bovine (cow) or ovine (sheep) materials.
Q: Is the effect of Hialuronidasa permanent or temporary?
The effect is consistently described as temporary in the official mechanism of action. The enzyme only causes a transient (short-lived) reduction in the tissue's viscosity by initiating the breakdown of hyaluronic acid.
Q: Can Hialuronidasa affect my blood pressure?
Changes in blood pressure are not listed among the most common side effects. However, severe and rare systemic allergic reactions, such as anaphylactic-like reactions, may include symptoms like a rapid pulse and a drop in blood pressure (hypotension).
Q: Is there a link between Hialuronidasa and inflammation?
Yes, there is a link described in the safety information. The enzyme is prohibited from being injected into or around an acutely inflamed or infected area due to the risk of inadvertently spreading the localized condition. Local inflammation (edema) at the injection site is also a reported reaction.
Q: What should I do if I experience unexpected effects after Hialuronidasa?
Regulatory information indicates that patients should report any unexpected or severe reactions, particularly signs of an allergic response such as hives, trouble breathing, or swelling, immediately to their healthcare professional. Discontinuation of the medicine is noted to be required if sensitization occurs.
